

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.63729638 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.34868271 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.22683022 |
| 4 | locomotory exploration behavior (GO:0035641) | 6.00055323 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.80209909 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.79391159 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.74107574 |
| 8 | vocalization behavior (GO:0071625) | 5.73538560 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.40959455 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.38233823 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.36854065 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.28813044 |
| 13 | protein localization to synapse (GO:0035418) | 5.13662536 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.08629358 |
| 15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.06762877 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.04655454 |
| 17 | glutamate secretion (GO:0014047) | 5.03841343 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.95251593 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.80896475 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 4.77411939 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.76886857 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.74335689 |
| 23 | exploration behavior (GO:0035640) | 4.70971478 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.70195350 |
| 25 | negative regulation of cell killing (GO:0031342) | 4.70195350 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.68197544 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.66443472 |
| 28 | response to peptidoglycan (GO:0032494) | 4.50093970 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.48476851 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 4.47960624 |
| 31 | neurotransmitter secretion (GO:0007269) | 4.46991426 |
| 32 | positive regulation of membrane potential (GO:0045838) | 4.46476693 |
| 33 | long-term memory (GO:0007616) | 4.45626321 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.41335671 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 4.41199722 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.37690778 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.35730041 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.30635530 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 4.22164278 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.21372994 |
| 41 | neuron cell-cell adhesion (GO:0007158) | 4.20945837 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19610838 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 4.18387076 |
| 44 | regulation of synaptic plasticity (GO:0048167) | 4.09616000 |
| 45 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.06456091 |
| 46 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.04996737 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 4.04525702 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.03016053 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.97128309 |
| 50 | dendritic spine morphogenesis (GO:0060997) | 3.95255586 |
| 51 | positive regulation of neurotransmitter transport (GO:0051590) | 3.90831031 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.88158040 |
| 53 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.86915858 |
| 54 | positive regulation of synapse maturation (GO:0090129) | 3.82340929 |
| 55 | regulation of glutamate secretion (GO:0014048) | 3.79499641 |
| 56 | long-term synaptic potentiation (GO:0060291) | 3.77462877 |
| 57 | behavioral defense response (GO:0002209) | 3.77155288 |
| 58 | behavioral fear response (GO:0001662) | 3.77155288 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.76960893 |
| 60 | transmission of nerve impulse (GO:0019226) | 3.72908271 |
| 61 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.68722834 |
| 62 | Peyers patch development (GO:0048541) | 3.68722834 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.67074863 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.66494411 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.63601631 |
| 66 | positive regulation of dendritic spine development (GO:0060999) | 3.63450250 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.62080064 |
| 68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61930321 |
| 69 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.61337281 |
| 70 | activation of protein kinase A activity (GO:0034199) | 3.60789113 |
| 71 | proline transport (GO:0015824) | 3.60721219 |
| 72 | detection of bacterium (GO:0016045) | 3.60680674 |
| 73 | negative regulation of amino acid transport (GO:0051956) | 3.60306850 |
| 74 | neurotransmitter transport (GO:0006836) | 3.58570966 |
| 75 | layer formation in cerebral cortex (GO:0021819) | 3.56772489 |
| 76 | detection of other organism (GO:0098543) | 3.55913467 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.55065145 |
| 78 | cellular potassium ion homeostasis (GO:0030007) | 3.53595497 |
| 79 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.52863767 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 3.52122312 |
| 81 | response to histamine (GO:0034776) | 3.51428804 |
| 82 | neuromuscular process controlling balance (GO:0050885) | 3.51021336 |
| 83 | leukocyte aggregation (GO:0070486) | 3.50537524 |
| 84 | regulation of dendritic spine development (GO:0060998) | 3.49951179 |
| 85 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49725171 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 3.47531661 |
| 87 | macrophage activation involved in immune response (GO:0002281) | 3.47388207 |
| 88 | positive thymic T cell selection (GO:0045059) | 3.46054113 |
| 89 | response to protozoan (GO:0001562) | 3.45118980 |
| 90 | neuromuscular process controlling posture (GO:0050884) | 3.44794579 |
| 91 | fear response (GO:0042596) | 3.43270914 |
| 92 | regulation of neurotransmitter levels (GO:0001505) | 3.42669442 |
| 93 | defense response to protozoan (GO:0042832) | 3.42568044 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.41347892 |
| 95 | prepulse inhibition (GO:0060134) | 3.40155832 |
| 96 | synaptic vesicle endocytosis (GO:0048488) | 3.40137948 |
| 97 | membrane depolarization (GO:0051899) | 3.39343537 |
| 98 | learning (GO:0007612) | 3.39201907 |
| 99 | postsynaptic membrane organization (GO:0001941) | 3.37340303 |
| 100 | response to muramyl dipeptide (GO:0032495) | 3.36529825 |
| 101 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.33462064 |
| 102 | neuronal ion channel clustering (GO:0045161) | 3.32837512 |
| 103 | mature B cell differentiation involved in immune response (GO:0002313) | 3.32605649 |
| 104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.31897453 |
| 105 | granulocyte activation (GO:0036230) | 3.30008885 |
| 106 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.29832383 |
| 107 | regulation of neurotransmitter transport (GO:0051588) | 3.29652595 |
| 108 | dendritic spine organization (GO:0097061) | 3.28883402 |
| 109 | auditory behavior (GO:0031223) | 3.28629892 |
| 110 | regulation of B cell differentiation (GO:0045577) | 3.28115776 |
| 111 | positive regulation of synaptic transmission (GO:0050806) | 3.26360627 |
| 112 | neuron recognition (GO:0008038) | 3.24246536 |
| 113 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.23967612 |
| 114 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.23684170 |
| 115 | visual learning (GO:0008542) | 3.23310765 |
| 116 | respiratory burst (GO:0045730) | 3.21681345 |
| 117 | regulation of synaptic transmission (GO:0050804) | 3.21300395 |
| 118 | ganglioside metabolic process (GO:0001573) | 3.20366473 |
| 119 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.19978985 |
| 120 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.18288120 |
| 121 | germinal center formation (GO:0002467) | 3.18279971 |
| 122 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.17940337 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 3.16965175 |
| 124 | synaptic transmission, dopaminergic (GO:0001963) | 3.16879486 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 3.16642788 |
| 126 | cellular extravasation (GO:0045123) | 3.16616889 |
| 127 | response to auditory stimulus (GO:0010996) | 3.14951556 |
| 128 | behavioral response to cocaine (GO:0048148) | 3.14336311 |
| 129 | membrane hyperpolarization (GO:0060081) | 3.14311886 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 3.14057990 |
| 131 | regulation of female receptivity (GO:0045924) | 3.12841531 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 3.12426518 |
| 133 | T cell migration (GO:0072678) | 3.12291763 |
| 134 | sodium ion export (GO:0071436) | 3.11168461 |
| 135 | positive regulation by symbiont of host defense response (GO:0052509) | 3.10657279 |
| 136 | modulation by symbiont of host defense response (GO:0052031) | 3.10657279 |
| 137 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.10657279 |
| 138 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.10657279 |
| 139 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.10657279 |
| 140 | modulation by symbiont of host immune response (GO:0052553) | 3.10657279 |
| 141 | membrane depolarization during action potential (GO:0086010) | 3.09944092 |
| 142 | synaptic transmission (GO:0007268) | 3.09924583 |
| 143 | myeloid dendritic cell differentiation (GO:0043011) | 3.06917736 |
| 144 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06898621 |
| 145 | visual behavior (GO:0007632) | 3.06851825 |
| 146 | response to amphetamine (GO:0001975) | 3.06609325 |
| 147 | regulation of leukocyte degranulation (GO:0043300) | 3.05946437 |
| 148 | neutrophil activation (GO:0042119) | 3.05810236 |
| 149 | associative learning (GO:0008306) | 3.03789439 |
| 150 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.02517037 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02498009 |
| 152 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.02398239 |
| 153 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.02398239 |
| 154 | oligosaccharide catabolic process (GO:0009313) | 2.99587560 |
| 155 | social behavior (GO:0035176) | 2.99089932 |
| 156 | intraspecies interaction between organisms (GO:0051703) | 2.99089932 |
| 157 | regulation of protein kinase A signaling (GO:0010738) | 2.98566020 |
| 158 | dopamine receptor signaling pathway (GO:0007212) | 2.97089625 |
| 159 | regulation of synapse maturation (GO:0090128) | 2.96606109 |
| 160 | response to interleukin-15 (GO:0070672) | 2.95913555 |
| 161 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94905893 |
| 162 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94665935 |
| 163 | cellular response to interleukin-15 (GO:0071350) | 2.94198257 |
| 164 | regulation of mast cell activation (GO:0033003) | 2.92964663 |
| 165 | negative thymic T cell selection (GO:0045060) | 2.92115429 |
| 166 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91405140 |
| 167 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.91259258 |
| 168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88998745 |
| 169 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88148075 |
| 170 | positive regulation of mast cell degranulation (GO:0043306) | 2.87503723 |
| 171 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.87503723 |
| 172 | leukocyte degranulation (GO:0043299) | 2.85418984 |
| 173 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85201430 |
| 174 | activated T cell proliferation (GO:0050798) | 2.84840663 |
| 175 | cellular response to type I interferon (GO:0071357) | 2.79524163 |
| 176 | type I interferon signaling pathway (GO:0060337) | 2.79524163 |
| 177 | negative regulation of phagocytosis (GO:0050765) | 2.78818504 |
| 178 | regulation of antigen processing and presentation (GO:0002577) | 2.78640573 |
| 179 | response to type I interferon (GO:0034340) | 2.78348407 |
| 180 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.78163946 |
| 181 | negative T cell selection (GO:0043383) | 2.77129606 |
| 182 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.76247129 |
| 183 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76221937 |
| 184 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74743574 |
| 185 | negative regulation of innate immune response (GO:0045824) | 2.71896191 |
| 186 | response to thyroid hormone (GO:0097066) | 2.71022745 |
| 187 | amino sugar catabolic process (GO:0046348) | 2.70444602 |
| 188 | detection of external biotic stimulus (GO:0098581) | 2.70086762 |
| 189 | glycosphingolipid catabolic process (GO:0046479) | 2.69765611 |
| 190 | B cell mediated immunity (GO:0019724) | 2.67159888 |
| 191 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.65979946 |
| 192 | B cell receptor signaling pathway (GO:0050853) | 2.65679039 |
| 193 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.65658656 |
| 194 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64139060 |
| 195 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.62320152 |
| 196 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.61791698 |
| 197 | positive T cell selection (GO:0043368) | 2.61596406 |
| 198 | regulation of regulated secretory pathway (GO:1903305) | 2.60458815 |
| 199 | positive regulation of granulocyte differentiation (GO:0030854) | 2.59411301 |
| 200 | thymic T cell selection (GO:0045061) | 2.59202798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.26169779 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.07328080 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.46769888 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.89661473 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.63982671 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.48248969 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.42587525 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.36804002 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.30879150 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.29514286 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.25443888 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15021242 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.05421653 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.05201365 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02993522 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.97508607 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.83206282 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.80250311 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75437309 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.74601100 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74360441 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74360441 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.74025426 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70142851 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.68769770 |
| 26 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.66128102 |
| 27 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64197477 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.56761291 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55912518 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.53981459 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.53587446 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52307325 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.48667694 |
| 34 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.46662494 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46499650 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.46341209 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44417351 |
| 38 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33966444 |
| 39 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25464856 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20883014 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.18248753 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 2.16937241 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16342932 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14741020 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10151516 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.07102181 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06583871 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06054627 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04735579 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04025634 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99515129 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.99384712 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97952606 |
| 54 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97524250 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.94156306 |
| 56 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91952466 |
| 57 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88966244 |
| 58 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86247029 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85591101 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84961537 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84939497 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83117765 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.82015371 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81847934 |
| 65 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.73624106 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.73295229 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72875943 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71049582 |
| 69 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67327662 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63359223 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62166830 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61565578 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60108587 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57430905 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55627418 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54725043 |
| 77 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53825614 |
| 78 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.51988615 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48358387 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.47968561 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44012293 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43936327 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43586149 |
| 84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.40773486 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40295265 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40064210 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 1.39811512 |
| 88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39684400 |
| 89 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.39681165 |
| 90 | * P68_20966046_ChIP-Seq_HELA_Human | 1.39633400 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37146876 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35575311 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34982762 |
| 94 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.34790497 |
| 95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33866313 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33620153 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33468911 |
| 98 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31079231 |
| 99 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30888117 |
| 100 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30275839 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29950603 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29406518 |
| 103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29371571 |
| 104 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28182080 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27385620 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24375724 |
| 107 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23312349 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.22454309 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22008691 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21505793 |
| 111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21467726 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20995958 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20447664 |
| 114 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20398119 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18569591 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16800490 |
| 117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16575269 |
| 118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16095090 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16032967 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15843012 |
| 121 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15088532 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14951064 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13868477 |
| 124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13859531 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13828214 |
| 126 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12952267 |
| 127 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12497417 |
| 128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12207000 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12048508 |
| 130 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11976102 |
| 131 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09578614 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09536178 |
| 133 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08667828 |
| 134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07494280 |
| 135 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07386066 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07356888 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07080786 |
| 138 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07015393 |
| 139 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06868054 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06671744 |
| 141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05726787 |
| 142 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05706637 |
| 143 | AR_19668381_ChIP-Seq_PC3_Human | 1.05463610 |
| 144 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.05194711 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04885234 |
| 146 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03250444 |
| 147 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03035073 |
| 148 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02695885 |
| 149 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.02484562 |
| 150 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01867878 |
| 151 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.01396610 |
| 152 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.01258840 |
| 153 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00655135 |
| 154 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99608702 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98787554 |
| 156 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98551155 |
| 157 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98329238 |
| 158 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97886410 |
| 159 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97517523 |
| 160 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93097350 |
| 161 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92314000 |
| 162 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91375266 |
| 163 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90617459 |
| 164 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90466843 |
| 165 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89918179 |
| 166 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89580698 |
| 167 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89041551 |
| 168 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87463351 |
| 169 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86711266 |
| 170 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85011948 |
| 171 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84400636 |
| 172 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83465093 |
| 173 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82184674 |
| 174 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81603360 |
| 175 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81601129 |
| 176 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80741962 |
| 177 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.79711045 |
| 178 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77986836 |
| 179 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76964254 |
| 180 | TP53_16413492_ChIP-PET_HCT116_Human | 0.75713930 |
| 181 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75509110 |
| 182 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75438729 |
| 183 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.75094331 |
| 184 | * JUN_21703547_ChIP-Seq_K562_Human | 0.74811047 |
| 185 | FUS_26573619_Chip-Seq_HEK293_Human | 0.74508565 |
| 186 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71555817 |
| 187 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.71421200 |
| 188 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71159111 |
| 189 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.71059054 |
| 190 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70713014 |
| 191 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.70713014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.45102721 |
| 2 | MP0003880_abnormal_central_pattern | 5.32515614 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.43921507 |
| 4 | MP0002822_catalepsy | 4.04490664 |
| 5 | MP0009745_abnormal_behavioral_response | 3.81782096 |
| 6 | MP0003436_decreased_susceptibility_to | 3.63914298 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.54925831 |
| 8 | MP0002064_seizures | 3.36285148 |
| 9 | MP0005671_abnormal_response_to | 3.35619314 |
| 10 | MP0004270_analgesia | 3.28181773 |
| 11 | MP0006082_CNS_inflammation | 3.27933525 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.05589866 |
| 13 | MP0003724_increased_susceptibility_to | 3.05266023 |
| 14 | MP0009278_abnormal_bone_marrow | 3.04581973 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 3.01770582 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.99859894 |
| 17 | MP0009046_muscle_twitch | 2.95843915 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.95241235 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.94203056 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.83663722 |
| 21 | MP0002419_abnormal_innate_immunity | 2.78515909 |
| 22 | MP0005025_abnormal_response_to | 2.73783231 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.67868078 |
| 24 | MP0002272_abnormal_nervous_system | 2.63941875 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.58830913 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.56898946 |
| 27 | MP0001486_abnormal_startle_reflex | 2.55336401 |
| 28 | MP0001790_abnormal_immune_system | 2.54630100 |
| 29 | MP0005387_immune_system_phenotype | 2.54630100 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.50184275 |
| 31 | MP0001800_abnormal_humoral_immune | 2.43894459 |
| 32 | MP0002723_abnormal_immune_serum | 2.42620656 |
| 33 | MP0002736_abnormal_nociception_after | 2.42391445 |
| 34 | MP0009785_altered_susceptibility_to | 2.41099542 |
| 35 | MP0002452_abnormal_antigen_presenting | 2.39843045 |
| 36 | MP0002420_abnormal_adaptive_immunity | 2.37535972 |
| 37 | MP0001819_abnormal_immune_cell | 2.35275465 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 2.24960030 |
| 39 | MP0005464_abnormal_platelet_physiology | 2.17054345 |
| 40 | MP0002735_abnormal_chemical_nociception | 2.15625857 |
| 41 | MP0002405_respiratory_system_inflammati | 2.05152289 |
| 42 | MP0000685_abnormal_immune_system | 1.96950717 |
| 43 | * MP0001545_abnormal_hematopoietic_system | 1.95056167 |
| 44 | * MP0005397_hematopoietic_system_phenotyp | 1.95056167 |
| 45 | MP0001970_abnormal_pain_threshold | 1.94088175 |
| 46 | MP0008569_lethality_at_weaning | 1.93123795 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.92424692 |
| 48 | MP0001440_abnormal_grooming_behavior | 1.92182319 |
| 49 | MP0003879_abnormal_hair_cell | 1.83798985 |
| 50 | * MP0002398_abnormal_bone_marrow | 1.83666510 |
| 51 | MP0000716_abnormal_immune_system | 1.81560278 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.79692842 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.78139229 |
| 54 | MP0003329_amyloid_beta_deposits | 1.77302320 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.77144848 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.76366395 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.71488261 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.69945637 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.68736430 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.65296231 |
| 61 | MP0005451_abnormal_body_composition | 1.62070332 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.62033505 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.61337013 |
| 64 | MP0004947_skin_inflammation | 1.61146943 |
| 65 | MP0005646_abnormal_pituitary_gland | 1.60115914 |
| 66 | MP0004924_abnormal_behavior | 1.59518402 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.59518402 |
| 68 | MP0002722_abnormal_immune_system | 1.57688492 |
| 69 | MP0008469_abnormal_protein_level | 1.53355778 |
| 70 | MP0001905_abnormal_dopamine_level | 1.52758252 |
| 71 | MP0001873_stomach_inflammation | 1.52233512 |
| 72 | MP0009840_abnormal_foam_cell | 1.50828875 |
| 73 | MP0003787_abnormal_imprinting | 1.50236259 |
| 74 | MP0003075_altered_response_to | 1.49698733 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.49465175 |
| 76 | MP0004142_abnormal_muscle_tone | 1.49081685 |
| 77 | MP0001529_abnormal_vocalization | 1.48949227 |
| 78 | MP0002429_abnormal_blood_cell | 1.48514721 |
| 79 | MP0009764_decreased_sensitivity_to | 1.46081174 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.45039535 |
| 81 | MP0004858_abnormal_nervous_system | 1.44076928 |
| 82 | MP0002184_abnormal_innervation | 1.42441008 |
| 83 | MP0003633_abnormal_nervous_system | 1.41757697 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 1.40012823 |
| 85 | MP0002066_abnormal_motor_capabilities/c | 1.34817317 |
| 86 | MP0000703_abnormal_thymus_morphology | 1.33573181 |
| 87 | MP0001853_heart_inflammation | 1.32834764 |
| 88 | MP0000955_abnormal_spinal_cord | 1.32310445 |
| 89 | MP0001188_hyperpigmentation | 1.30770456 |
| 90 | MP0004885_abnormal_endolymph | 1.30581203 |
| 91 | MP0001984_abnormal_olfaction | 1.27281991 |
| 92 | MP0000778_abnormal_nervous_system | 1.26574911 |
| 93 | MP0001502_abnormal_circadian_rhythm | 1.24342049 |
| 94 | MP0008874_decreased_physiological_sensi | 1.23633934 |
| 95 | MP0002882_abnormal_neuron_morphology | 1.22818885 |
| 96 | MP0006276_abnormal_autonomic_nervous | 1.22648437 |
| 97 | MP0002998_abnormal_bone_remodeling | 1.21714328 |
| 98 | MP0008872_abnormal_physiological_respon | 1.20673388 |
| 99 | MP0000343_altered_response_to | 1.20179471 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 1.18604974 |
| 101 | MP0002396_abnormal_hematopoietic_system | 1.15396192 |
| 102 | MP0003631_nervous_system_phenotype | 1.11883358 |
| 103 | MP0003866_abnormal_defecation | 1.07107207 |
| 104 | MP0002139_abnormal_hepatobiliary_system | 1.05622248 |
| 105 | MP0005409_darkened_coat_color | 1.04177062 |
| 106 | * MP0004808_abnormal_hematopoietic_stem | 1.02986062 |
| 107 | MP0001851_eye_inflammation | 1.02273899 |
| 108 | MP0003122_maternal_imprinting | 1.01106614 |
| 109 | MP0000490_abnormal_crypts_of | 1.00384370 |
| 110 | MP0000751_myopathy | 0.98244236 |
| 111 | MP0003448_altered_tumor_morphology | 0.97524606 |
| 112 | MP0000858_altered_metastatic_potential | 0.97111451 |
| 113 | MP0004510_myositis | 0.96305942 |
| 114 | MP0003690_abnormal_glial_cell | 0.94987680 |
| 115 | MP0005535_abnormal_body_temperature | 0.94233416 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.91858311 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.91710584 |
| 118 | MP0002152_abnormal_brain_morphology | 0.91359178 |
| 119 | MP0000604_amyloidosis | 0.90904134 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.90137031 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.88519225 |
| 122 | MP0002229_neurodegeneration | 0.85760784 |
| 123 | MP0000920_abnormal_myelination | 0.84166352 |
| 124 | MP0009763_increased_sensitivity_to | 0.80352637 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.78488045 |
| 126 | MP0001177_atelectasis | 0.77856829 |
| 127 | MP0001663_abnormal_digestive_system | 0.77785827 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.77162304 |
| 129 | MP0001664_abnormal_digestion | 0.75315368 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.74385109 |
| 131 | MP0001963_abnormal_hearing_physiology | 0.71514287 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.70779475 |
| 133 | MP0002876_abnormal_thyroid_physiology | 0.70257025 |
| 134 | MP0004085_abnormal_heartbeat | 0.68993296 |
| 135 | MP0002933_joint_inflammation | 0.68729345 |
| 136 | MP0002019_abnormal_tumor_incidence | 0.68269843 |
| 137 | MP0005390_skeleton_phenotype | 0.67984866 |
| 138 | MP0005647_abnormal_sex_gland | 0.66088045 |
| 139 | MP0005166_decreased_susceptibility_to | 0.65994127 |
| 140 | MP0006036_abnormal_mitochondrial_physio | 0.65414872 |
| 141 | MP0003828_pulmonary_edema | 0.65344359 |
| 142 | MP0002138_abnormal_hepatobiliary_system | 0.64993754 |
| 143 | MP0003632_abnormal_nervous_system | 0.64350526 |
| 144 | MP0004145_abnormal_muscle_electrophysio | 0.62830684 |
| 145 | MP0003634_abnormal_glial_cell | 0.62618438 |
| 146 | MP0002132_abnormal_respiratory_system | 0.61522205 |
| 147 | MP0005551_abnormal_eye_electrophysiolog | 0.61343996 |
| 148 | MP0002090_abnormal_vision | 0.61277144 |
| 149 | MP0003183_abnormal_peptide_metabolism | 0.60736049 |
| 150 | MP0003303_peritoneal_inflammation | 0.60318833 |
| 151 | MP0003795_abnormal_bone_structure | 0.59860073 |
| 152 | MP0002332_abnormal_exercise_endurance | 0.59823104 |
| 153 | MP0005165_increased_susceptibility_to | 0.57799918 |
| 154 | MP0000631_abnormal_neuroendocrine_gland | 0.57076335 |
| 155 | MP0004185_abnormal_adipocyte_glucose | 0.56616615 |
| 156 | MP0000681_abnormal_thyroid_gland | 0.56568017 |
| 157 | MP0006292_abnormal_olfactory_placode | 0.56358927 |
| 158 | MP0001765_abnormal_ion_homeostasis | 0.55694245 |
| 159 | MP0001485_abnormal_pinna_reflex | 0.55624231 |
| 160 | MP0008873_increased_physiological_sensi | 0.55337663 |
| 161 | MP0008004_abnormal_stomach_pH | 0.55302672 |
| 162 | MP0001986_abnormal_taste_sensitivity | 0.55269907 |
| 163 | MP0005334_abnormal_fat_pad | 0.54174426 |
| 164 | MP0003453_abnormal_keratinocyte_physiol | 0.53623163 |
| 165 | MP0004742_abnormal_vestibular_system | 0.53442935 |
| 166 | MP0002254_reproductive_system_inflammat | 0.52789066 |
| 167 | MP0010234_abnormal_vibrissa_follicle | 0.51649096 |
| 168 | MP0010386_abnormal_urinary_bladder | 0.51585512 |
| 169 | MP0005310_abnormal_salivary_gland | 0.51051872 |
| 170 | MP0000013_abnormal_adipose_tissue | 0.49646477 |
| 171 | MP0002752_abnormal_somatic_nervous | 0.49385525 |
| 172 | MP0003956_abnormal_body_size | 0.48661011 |
| 173 | MP0005174_abnormal_tail_pigmentation | 0.48575515 |
| 174 | MP0003123_paternal_imprinting | 0.47314520 |
| 175 | MP0004484_altered_response_of | 0.47039879 |
| 176 | MP0002638_abnormal_pupillary_reflex | 0.44814273 |
| 177 | MP0000015_abnormal_ear_pigmentation | 0.44245892 |
| 178 | MP0010769_abnormal_survival | 0.44011302 |
| 179 | MP0001943_abnormal_respiration | 0.42147936 |
| 180 | MP0010768_mortality/aging | 0.41838073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.74869851 |
| 2 | Myokymia (HP:0002411) | 7.85580817 |
| 3 | Focal seizures (HP:0007359) | 6.13224976 |
| 4 | Visual hallucinations (HP:0002367) | 6.05236803 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.41831799 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.25914900 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.25914900 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 5.25914900 |
| 9 | Epileptic encephalopathy (HP:0200134) | 5.03782347 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.97334349 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.84150911 |
| 12 | Stomatitis (HP:0010280) | 4.83039967 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.71746231 |
| 14 | Atonic seizures (HP:0010819) | 4.60146970 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 4.58605813 |
| 16 | Febrile seizures (HP:0002373) | 4.54456743 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.19584755 |
| 18 | Absence seizures (HP:0002121) | 4.17937141 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 4.16898574 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 4.14668320 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 4.07928409 |
| 22 | Dialeptic seizures (HP:0011146) | 3.98162151 |
| 23 | Myositis (HP:0100614) | 3.92175140 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 3.91306991 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.88658913 |
| 26 | Obstructive lung disease (HP:0006536) | 3.88658913 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.83113542 |
| 28 | Poor eye contact (HP:0000817) | 3.81536616 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.70300597 |
| 30 | Papilledema (HP:0001085) | 3.69286575 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 3.67802323 |
| 32 | Broad-based gait (HP:0002136) | 3.67515524 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 3.63285737 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.59781338 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.54319053 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54245148 |
| 37 | Depression (HP:0000716) | 3.48228962 |
| 38 | Ankle clonus (HP:0011448) | 3.37015339 |
| 39 | Anxiety (HP:0000739) | 3.33776545 |
| 40 | Loss of speech (HP:0002371) | 3.31685649 |
| 41 | Impaired social interactions (HP:0000735) | 3.30812437 |
| 42 | Abnormal social behavior (HP:0012433) | 3.30812437 |
| 43 | Mutism (HP:0002300) | 3.29247420 |
| 44 | Action tremor (HP:0002345) | 3.28547011 |
| 45 | Orchitis (HP:0100796) | 3.27723019 |
| 46 | Postural instability (HP:0002172) | 3.25655037 |
| 47 | Dysmetria (HP:0001310) | 3.24045477 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 3.22335624 |
| 49 | Abnormal eating behavior (HP:0100738) | 3.19344936 |
| 50 | Annular pancreas (HP:0001734) | 3.18593964 |
| 51 | Recurrent skin infections (HP:0001581) | 3.17970374 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 3.13419120 |
| 53 | Optic neuritis (HP:0100653) | 3.13419120 |
| 54 | Impaired smooth pursuit (HP:0007772) | 3.11209399 |
| 55 | Stereotypic behavior (HP:0000733) | 3.08185617 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.07320718 |
| 57 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05906962 |
| 58 | Meningitis (HP:0001287) | 3.05093655 |
| 59 | Disinhibition (HP:0000734) | 3.03633694 |
| 60 | Truncal ataxia (HP:0002078) | 3.02673918 |
| 61 | Dysdiadochokinesis (HP:0002075) | 3.02673781 |
| 62 | T lymphocytopenia (HP:0005403) | 3.01513761 |
| 63 | Torticollis (HP:0000473) | 2.98039067 |
| 64 | Hyperventilation (HP:0002883) | 2.94484689 |
| 65 | Increased serum ferritin (HP:0003281) | 2.92616219 |
| 66 | Focal dystonia (HP:0004373) | 2.88672418 |
| 67 | Recurrent viral infections (HP:0004429) | 2.87541185 |
| 68 | Petechiae (HP:0000967) | 2.84295870 |
| 69 | Amblyopia (HP:0000646) | 2.82752627 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.80295417 |
| 71 | Diplopia (HP:0000651) | 2.80295417 |
| 72 | Progressive inability to walk (HP:0002505) | 2.80198370 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78668555 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78668555 |
| 75 | Bradykinesia (HP:0002067) | 2.78517608 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.77743426 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.76797388 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.73566057 |
| 79 | Abnormality of the lower motor neuron (HP:0002366) | 2.73078881 |
| 80 | Genetic anticipation (HP:0003743) | 2.71282812 |
| 81 | Scanning speech (HP:0002168) | 2.67633595 |
| 82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.67065012 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.66872226 |
| 84 | Agnosia (HP:0010524) | 2.66080071 |
| 85 | Severe visual impairment (HP:0001141) | 2.65957697 |
| 86 | Encephalitis (HP:0002383) | 2.63883339 |
| 87 | Hemiplegia (HP:0002301) | 2.61148664 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.59322046 |
| 89 | Craniofacial dystonia (HP:0012179) | 2.58496209 |
| 90 | Prolonged bleeding time (HP:0003010) | 2.56607149 |
| 91 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.52560046 |
| 92 | Spastic gait (HP:0002064) | 2.51885557 |
| 93 | Pustule (HP:0200039) | 2.51241450 |
| 94 | Hemiparesis (HP:0001269) | 2.51043054 |
| 95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49461609 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49461609 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49461609 |
| 98 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44914597 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.44756229 |
| 100 | Abnormality of T cells (HP:0002843) | 2.43455111 |
| 101 | Impaired vibratory sensation (HP:0002495) | 2.39395599 |
| 102 | Urinary urgency (HP:0000012) | 2.38578224 |
| 103 | Upper motor neuron abnormality (HP:0002127) | 2.37882247 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 2.37391021 |
| 105 | Increased IgM level (HP:0003496) | 2.37063442 |
| 106 | Purpura (HP:0000979) | 2.36392934 |
| 107 | Status epilepticus (HP:0002133) | 2.36151264 |
| 108 | Gingivitis (HP:0000230) | 2.35661496 |
| 109 | Vasculitis (HP:0002633) | 2.34355739 |
| 110 | Mucopolysacchariduria (HP:0008155) | 2.32385531 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32385531 |
| 112 | Combined immunodeficiency (HP:0005387) | 2.29427996 |
| 113 | Keratoconjunctivitis sicca (HP:0001097) | 2.29301828 |
| 114 | Intention tremor (HP:0002080) | 2.27850100 |
| 115 | Urticaria (HP:0001025) | 2.27646620 |
| 116 | Pointed chin (HP:0000307) | 2.27476633 |
| 117 | Obstructive sleep apnea (HP:0002870) | 2.26026693 |
| 118 | Prostate neoplasm (HP:0100787) | 2.25042250 |
| 119 | Dysmetric saccades (HP:0000641) | 2.24955909 |
| 120 | Inability to walk (HP:0002540) | 2.23609507 |
| 121 | Inflammation of the large intestine (HP:0002037) | 2.22560574 |
| 122 | Cellulitis (HP:0100658) | 2.22346374 |
| 123 | Pulmonary infiltrates (HP:0002113) | 2.21909618 |
| 124 | Increased IgE level (HP:0003212) | 2.20731339 |
| 125 | Granulocytopenia (HP:0001913) | 2.20252203 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 2.19574023 |
| 127 | Cerebral inclusion bodies (HP:0100314) | 2.19489282 |
| 128 | Psychosis (HP:0000709) | 2.19087675 |
| 129 | Neurofibrillary tangles (HP:0002185) | 2.18993759 |
| 130 | Generalized aminoaciduria (HP:0002909) | 2.18574220 |
| 131 | Excessive salivation (HP:0003781) | 2.18572366 |
| 132 | Drooling (HP:0002307) | 2.18572366 |
| 133 | Polyphagia (HP:0002591) | 2.18258795 |
| 134 | Keratoconjunctivitis (HP:0001096) | 2.17917145 |
| 135 | Spinal canal stenosis (HP:0003416) | 2.17764232 |
| 136 | Abnormality of saccadic eye movements (HP:0000570) | 2.16024435 |
| 137 | Retinal dysplasia (HP:0007973) | 2.14803118 |
| 138 | Neuronal loss in central nervous system (HP:0002529) | 2.14534919 |
| 139 | Leukocytosis (HP:0001974) | 2.14370055 |
| 140 | Hemoptysis (HP:0002105) | 2.13300362 |
| 141 | Abnormality of the prostate (HP:0008775) | 2.13044053 |
| 142 | Episodic fever (HP:0001954) | 2.12987504 |
| 143 | Epileptiform EEG discharges (HP:0011182) | 2.12065747 |
| 144 | Spontaneous hematomas (HP:0007420) | 2.11395850 |
| 145 | Epistaxis (HP:0000421) | 2.10969755 |
| 146 | Generalized myoclonic seizures (HP:0002123) | 2.09284246 |
| 147 | Lower limb amyotrophy (HP:0007210) | 2.06471343 |
| 148 | Gastrointestinal infarctions (HP:0005244) | 2.05612578 |
| 149 | Rigidity (HP:0002063) | 2.05515746 |
| 150 | Resting tremor (HP:0002322) | 2.03070906 |
| 151 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02764210 |
| 152 | Ventricular fibrillation (HP:0001663) | 2.02347385 |
| 153 | Type II lissencephaly (HP:0007260) | 2.01850012 |
| 154 | Incomplete penetrance (HP:0003829) | 2.01605832 |
| 155 | Inappropriate behavior (HP:0000719) | 2.00133523 |
| 156 | Personality changes (HP:0000751) | 2.00025616 |
| 157 | Hypertensive crisis (HP:0100735) | 1.99410264 |
| 158 | Delusions (HP:0000746) | 1.98263811 |
| 159 | Absent speech (HP:0001344) | 1.97336532 |
| 160 | Hematochezia (HP:0002573) | 1.96538946 |
| 161 | Agammaglobulinemia (HP:0004432) | 1.96373146 |
| 162 | Global brain atrophy (HP:0002283) | 1.95935895 |
| 163 | Iris hypopigmentation (HP:0007730) | 1.94819887 |
| 164 | Lower limb muscle weakness (HP:0007340) | 1.94808994 |
| 165 | Fetal akinesia sequence (HP:0001989) | 1.92475529 |
| 166 | Thoracic kyphosis (HP:0002942) | 1.91916759 |
| 167 | Limb dystonia (HP:0002451) | 1.91906434 |
| 168 | Ragged-red muscle fibers (HP:0003200) | 1.91804322 |
| 169 | Decreased circulating renin level (HP:0003351) | 1.90837218 |
| 170 | Diminished motivation (HP:0000745) | 1.89937403 |
| 171 | Apathy (HP:0000741) | 1.89388862 |
| 172 | Gait ataxia (HP:0002066) | 1.89294271 |
| 173 | Abnormal EKG (HP:0003115) | 1.89249692 |
| 174 | Axonal loss (HP:0003447) | 1.89102853 |
| 175 | Protruding tongue (HP:0010808) | 1.89038939 |
| 176 | Severe combined immunodeficiency (HP:0004430) | 1.88795372 |
| 177 | Lower limb asymmetry (HP:0100559) | 1.88280313 |
| 178 | Abnormality of T cell physiology (HP:0011840) | 1.88149816 |
| 179 | Thrombocytosis (HP:0001894) | 1.87692655 |
| 180 | Abnormality of B cell number (HP:0010975) | 1.87257442 |
| 181 | Polyneuropathy (HP:0001271) | 1.87100902 |
| 182 | Insomnia (HP:0100785) | 1.85934789 |
| 183 | Dyskinesia (HP:0100660) | 1.84552819 |
| 184 | Hypergammaglobulinemia (HP:0010702) | 1.84359183 |
| 185 | EEG with generalized epileptiform discharges (HP:0011198) | 1.84212160 |
| 186 | Limb ataxia (HP:0002070) | 1.82889285 |
| 187 | Sleep apnea (HP:0010535) | 1.82045189 |
| 188 | Chest pain (HP:0100749) | 1.81989595 |
| 189 | Abnormality of the periventricular white matter (HP:0002518) | 1.81262551 |
| 190 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80662636 |
| 191 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79119443 |
| 192 | Absent/shortened dynein arms (HP:0200106) | 1.79119443 |
| 193 | Rapidly progressive (HP:0003678) | 1.77984468 |
| 194 | Ankyloglossia (HP:0010296) | 1.76382469 |
| 195 | Increased circulating renin level (HP:0000848) | 1.76199262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.87696289 |
| 2 | NTRK3 | 4.89179145 |
| 3 | MAP4K1 | 4.00227776 |
| 4 | MAP3K9 | 3.83816167 |
| 5 | NME2 | 3.54276726 |
| 6 | TXK | 2.94857574 |
| 7 | TNIK | 2.93720004 |
| 8 | RIPK4 | 2.72949192 |
| 9 | MAP3K11 | 2.66552497 |
| 10 | MAP3K12 | 2.63943841 |
| 11 | DAPK2 | 2.57790238 |
| 12 | TESK2 | 2.40382356 |
| 13 | MINK1 | 2.37150324 |
| 14 | MAP2K3 | 2.33450137 |
| 15 | KSR2 | 2.28560555 |
| 16 | MAP3K4 | 2.28039498 |
| 17 | MAP2K7 | 2.27290241 |
| 18 | FES | 2.15480643 |
| 19 | DAPK1 | 2.15083044 |
| 20 | MAP3K13 | 2.13639120 |
| 21 | IRAK3 | 2.05183154 |
| 22 | ARAF | 2.04937510 |
| 23 | TAOK2 | 2.00713006 |
| 24 | MAP3K14 | 1.97325678 |
| 25 | CAMKK1 | 1.96716988 |
| 26 | CDK19 | 1.92746026 |
| 27 | TBK1 | 1.86595060 |
| 28 | NTRK2 | 1.85114032 |
| 29 | MARK1 | 1.83626884 |
| 30 | BLK | 1.81121211 |
| 31 | TAOK3 | 1.78689743 |
| 32 | BTK | 1.78473023 |
| 33 | GRK7 | 1.78466769 |
| 34 | PAK6 | 1.73849695 |
| 35 | TYK2 | 1.72912847 |
| 36 | JAK3 | 1.71473291 |
| 37 | CSK | 1.70536571 |
| 38 | SIK2 | 1.66188690 |
| 39 | BCKDK | 1.65915522 |
| 40 | PRKD3 | 1.62521928 |
| 41 | KDR | 1.61516704 |
| 42 | KIT | 1.60233961 |
| 43 | IKBKB | 1.59042821 |
| 44 | IRAK4 | 1.56652749 |
| 45 | CDK5 | 1.55777449 |
| 46 | KSR1 | 1.55075184 |
| 47 | MAP2K4 | 1.53605042 |
| 48 | ZAP70 | 1.53547338 |
| 49 | RAF1 | 1.49666261 |
| 50 | ERN1 | 1.49267583 |
| 51 | PRPF4B | 1.48043320 |
| 52 | PIM2 | 1.45698386 |
| 53 | PLK2 | 1.45208975 |
| 54 | MATK | 1.43920191 |
| 55 | TEC | 1.41596547 |
| 56 | IKBKE | 1.39561424 |
| 57 | ITK | 1.38560393 |
| 58 | CAMKK2 | 1.30430467 |
| 59 | CAMK1 | 1.30122311 |
| 60 | TAOK1 | 1.28282129 |
| 61 | CASK | 1.27609126 |
| 62 | MAPK13 | 1.25448309 |
| 63 | GRK5 | 1.23168711 |
| 64 | NTRK1 | 1.21647747 |
| 65 | LCK | 1.20471196 |
| 66 | MARK2 | 1.13564637 |
| 67 | LYN | 1.13486977 |
| 68 | PRKCG | 1.11842937 |
| 69 | TGFBR2 | 1.07924428 |
| 70 | TNK2 | 1.03767498 |
| 71 | STK38 | 1.01307936 |
| 72 | MAP3K3 | 0.99042845 |
| 73 | ABL2 | 0.93024339 |
| 74 | CSF1R | 0.90481589 |
| 75 | UHMK1 | 0.90268284 |
| 76 | CAMK2A | 0.89446036 |
| 77 | RPS6KL1 | 0.87281467 |
| 78 | RPS6KC1 | 0.87281467 |
| 79 | PIM1 | 0.87176577 |
| 80 | MAP3K2 | 0.86808706 |
| 81 | PTK2B | 0.86791316 |
| 82 | CAMK2B | 0.86569548 |
| 83 | TYRO3 | 0.85879111 |
| 84 | CDK18 | 0.79738559 |
| 85 | CDK15 | 0.78696906 |
| 86 | MAP3K1 | 0.78399587 |
| 87 | JAK1 | 0.78324767 |
| 88 | JAK2 | 0.77785247 |
| 89 | STK11 | 0.77322577 |
| 90 | PRKCH | 0.77275335 |
| 91 | PDK1 | 0.77002778 |
| 92 | RPS6KA6 | 0.76533130 |
| 93 | MUSK | 0.75654953 |
| 94 | MARK3 | 0.72917557 |
| 95 | BMPR2 | 0.72743482 |
| 96 | SCYL2 | 0.72523883 |
| 97 | CDK11A | 0.71545468 |
| 98 | CDK14 | 0.69692674 |
| 99 | CSNK1G2 | 0.68714823 |
| 100 | PINK1 | 0.65093810 |
| 101 | MAPK4 | 0.63376837 |
| 102 | SGK1 | 0.62031643 |
| 103 | PDPK1 | 0.61912348 |
| 104 | MAP2K2 | 0.61487096 |
| 105 | ALK | 0.60543163 |
| 106 | CDK4 | 0.58121979 |
| 107 | CDC42BPA | 0.57587308 |
| 108 | SYK | 0.57285861 |
| 109 | DYRK1A | 0.56444195 |
| 110 | STK10 | 0.56228629 |
| 111 | PNCK | 0.55214406 |
| 112 | CCNB1 | 0.54955172 |
| 113 | PRKCQ | 0.54373816 |
| 114 | MAP3K7 | 0.53781654 |
| 115 | RET | 0.52943121 |
| 116 | CAMK4 | 0.51950713 |
| 117 | MAPK11 | 0.50312697 |
| 118 | BRAF | 0.49774814 |
| 119 | DAPK3 | 0.49759457 |
| 120 | FYN | 0.49013254 |
| 121 | HIPK2 | 0.48496405 |
| 122 | IRAK2 | 0.46590142 |
| 123 | OXSR1 | 0.46554939 |
| 124 | RPS6KA4 | 0.46186538 |
| 125 | MAP3K6 | 0.46037611 |
| 126 | BRSK1 | 0.45003565 |
| 127 | GRK6 | 0.42662475 |
| 128 | FGR | 0.42379359 |
| 129 | MAPK7 | 0.41964260 |
| 130 | RPS6KA3 | 0.41640253 |
| 131 | MAP2K6 | 0.41446547 |
| 132 | TRIB3 | 0.41312395 |
| 133 | SGK223 | 0.40613101 |
| 134 | SGK494 | 0.40613101 |
| 135 | MOS | 0.40507185 |
| 136 | NME1 | 0.40449275 |
| 137 | MAP3K5 | 0.39822232 |
| 138 | MAPKAPK5 | 0.39525252 |
| 139 | SIK3 | 0.38186697 |
| 140 | NEK6 | 0.38012412 |
| 141 | ADRBK2 | 0.37481279 |
| 142 | SGK2 | 0.35484577 |
| 143 | RPS6KA1 | 0.34603732 |
| 144 | CAMK2G | 0.34372833 |
| 145 | PRKD2 | 0.33409467 |
| 146 | DMPK | 0.32804298 |
| 147 | TESK1 | 0.32761975 |
| 148 | HCK | 0.32737259 |
| 149 | CAMK2D | 0.32534349 |
| 150 | PRKCE | 0.32393844 |
| 151 | PHKG2 | 0.32347179 |
| 152 | PHKG1 | 0.32347179 |
| 153 | CAMK1D | 0.32273131 |
| 154 | PRKCZ | 0.31353110 |
| 155 | MAPK10 | 0.30941530 |
| 156 | PRKCD | 0.30058484 |
| 157 | RPS6KA2 | 0.30032899 |
| 158 | SGK3 | 0.29244725 |
| 159 | MAPK12 | 0.28576984 |
| 160 | PRKCA | 0.28437152 |
| 161 | PRKG2 | 0.26572184 |
| 162 | MAPK3 | 0.25573171 |
| 163 | ABL1 | 0.22244130 |
| 164 | RPS6KB2 | 0.21799090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.93977419 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.36783892 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.16238050 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.16111788 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.95730394 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.90533204 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.87696237 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.80510230 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.79270730 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78944226 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.78736399 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.77735407 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.72637244 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71901970 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.70844365 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 2.52051910 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.48862496 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.47820001 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26989226 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21364842 |
| 21 | Asthma_Homo sapiens_hsa05310 | 2.21325081 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 2.21065570 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19769017 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.12695858 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08432185 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.07058204 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04848750 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.99700186 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.99569354 |
| 30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98315597 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97767720 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97385126 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92137416 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.88974538 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.85961953 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.80917605 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75939913 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75567760 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.74804230 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69741650 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.69694041 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.65695864 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64829203 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.61677588 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.60885609 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56741611 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50231149 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49316431 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.41313258 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41022593 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.40629182 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.39811732 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.37641252 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37176515 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34227932 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.33419062 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30487938 |
| 58 | Measles_Homo sapiens_hsa05162 | 1.27490171 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25183100 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 1.21974805 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21110250 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19973522 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17780819 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17493327 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 1.16730919 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13608128 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12275218 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 1.10010750 |
| 69 | Glioma_Homo sapiens_hsa05214 | 1.09472587 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06373093 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.03035065 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01689869 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01099998 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97567211 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94079234 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93557480 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91879343 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.90864648 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90364881 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90126048 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.84544945 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82119771 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80762757 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78420536 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75174756 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.74402839 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74158163 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73896734 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72868094 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71497932 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.71016715 |
| 92 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70952479 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70788497 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69400293 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68240719 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.66885550 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65861393 |
| 98 | Phototransduction_Homo sapiens_hsa04744 | 0.65620656 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.64898118 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.62506963 |
| 101 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61852597 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61416478 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61151740 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60303234 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58504052 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58289739 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58153536 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58048032 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57230150 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55850786 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54582103 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53844001 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53789075 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53014949 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52880725 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52546579 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51777871 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51259372 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.51141157 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50967281 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49682406 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49089654 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48864328 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46524932 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.46128633 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45273821 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43736360 |
| 128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41830358 |
| 129 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39937538 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39775962 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39422882 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39202659 |
| 133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38971431 |
| 134 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36276476 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.35686024 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35091874 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33685860 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33017626 |
| 139 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32717158 |
| 140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32714905 |
| 141 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30718500 |
| 142 | Base excision repair_Homo sapiens_hsa03410 | 0.28677353 |
| 143 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28600061 |
| 144 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28583099 |
| 145 | Tuberculosis_Homo sapiens_hsa05152 | 0.27905174 |
| 146 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25366918 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24741969 |
| 148 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23831879 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23650861 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | 0.23647031 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23256467 |
| 152 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23129452 |
| 153 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22521557 |
| 154 | Salmonella infection_Homo sapiens_hsa05132 | 0.22312082 |
| 155 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22134614 |
| 156 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21731790 |
| 157 | Ribosome_Homo sapiens_hsa03010 | 0.21652984 |
| 158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20176720 |
| 159 | Amoebiasis_Homo sapiens_hsa05146 | 0.17005279 |
| 160 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16916052 |
| 161 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.15077054 |

